Field-applicable simultaneous multiplex LAMP assay for screening HBV and HCV co-infection in a single tube

被引:0
|
作者
Agel, Esra [1 ]
Altin, Kevser Hanne [2 ]
机构
[1] Sensor Technol Res Grp TUBITAK Marmara Res Ctr, Sci & Technol Res Council Turkiye, TR-41470 Gebze, Kocaeli, Turkiye
[2] Istanbul Medipol Univ, Dept Med Microbiol, TR-34815 Istanbul, Turkiye
关键词
Multiplex LAMP; Isothermal amplification; Lateral flow dipstick; Rapid diagnostics; Point of care; LATERAL FLOW DIPSTICK; AMPLIFICATION;
D O I
10.1186/s12879-024-09567-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundGlobally, around 7 to 20 million people are believed to be suffering from coinfection with both hepatitis B virus (HBV) and hepatitis C virus (HCV). The loop-mediated isothermal amplification (LAMP) approach, introduced by Notomi and colleagues, has undergone substantial advancements as an effective molecular tool that enables the simultaneous analysis of multiple samples in a single tube.MethodsThe present study examined the simultaneous detection of HBV and HCV in a single tube using melt curve analysis multiplex LAMP (mLAMP), which is based on the identification of unique melting peak temperatures. Selected regions for primer design including the S gene of HBV and the UTR gene of HCV. Primer optimization is initially performed through individual HBV and HCV LAMP analysis. Following the optimization process, the mLAMP assay was evaluated by optimizing the multiplex reaction mixture, determining the reaction time, and analyzing the limit of detection (LOD). The results are also analyzed using lateral flow dipsticks (LFD), which enable the visual detection of HBV and HCV by adding 20 pmol FITC-labeled LF primers into the reaction mixture prior the mLAMP.ResultsThe LOD for the mLAMP assay was determined as 10 copies/mu l, and no cross-reactivity with other microorganisms was detected. The detection results obtained from patient plasma were also visually demonstrated using LFD, and displayed significant concordance with those obtained from Real-Time Polymerase Chain Assay. The mLAMP assay revealed a diagnostic sensitivity of 95% for detecting the HBV, and LOD is 90% for HCV. The overall diagnostic sensitivity of the mLAMP assay for both viruses was 85%. The assay confirmed a specificity of 100%.ConclusionThe mLAMP assay displays significant promise for analyzing coinfected samples by simultaneously detecting the dual targets HBV and HCV within a set temperature of 62 degrees C, all within a time frame of 1 h. Additionally, when paired with disposable LFD, the mLAMP assay enables rapid visual detection of assay results in a matter of minutes. The result contributes to the mLAMP assay being highly suitable for coinfection screening, particularly in field conditions.
引用
收藏
页数:13
相关论文
共 6 条
  • [1] Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection
    M. S. De Mitri
    G. Morsica
    R. Cassini
    S. Bagaglio
    P. Andreone
    G. Bianchi
    M. Margotti
    M. Bernardi
    Archives of Virology, 2005, 150 : 261 - 271
  • [2] Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection
    De Mitri, MS
    Morsica, G
    Cassini, R
    Bagaglio, S
    Andreone, P
    Bianchi, G
    Margotti, M
    Bernardi, M
    ARCHIVES OF VIROLOGY, 2005, 150 (02) : 261 - 271
  • [3] An automated multiplex assay system for the simultaneous screening of HIV-1, HCV, and HBV in human plasma
    Impraim, C
    Fiss, E
    Iwata, K
    Meng, Q
    Pandya, S
    Parra, H
    Rangachari, AS
    Sasaki, M
    Tamakura, S
    Wong, C
    Yawata, H
    Hirose, T
    TRANSFUSION, 1999, 39 (10) : 65S - 65S
  • [4] Predictive Factors for Cirrhosis in Chronic Hepatitis B Mono-Infection Compared to HBV/Hdv, and HBV/HCV Co-Infection: Single Center Experience from Lahore
    Omar, Muhammad
    Khan, Amjad
    Altaf, Amna
    Omar, Raja
    Naveed, Ammara
    Mahboobul-Haq
    Ghani, Usman
    Akhtar, Saeed
    Siddiqui, Arif
    Nadir, Abdul
    HEPATOLOGY, 2018, 68 : 1235A - 1236A
  • [5] Evaluation of Long Term Outcome After Living Donor Liver Transplantation in Sequential 653 Recipients with or without Viral Infection: Is HBV & HCV Co-Infection Better Than the Monoinfection? A Single Center Retrospective Analysis.
    Yang, H.
    Thorat, A.
    Jeng, L.
    Yeh, C. -C.
    Chen, T. -H.
    Hsu, S. -C.
    Poon, K. -S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 790 - 791
  • [6] THE EFFICACY AND SAFETY OF 12-WEEK SOF/VEL REGIMEN COMBINED WITH PROPHYLACTIC USE OF TAF FOR TREATMENT-NAIVE genotype1-6 HCV/HBV CO-INFECTION ADULT PATIENTS WITH OR WITHOUT COMPENSATED CIRRHOSIS IN CHINA: A MULTI-CENTER PROSPECTIVE, SINGLE-ARM, OPENLABEL TRIAL
    Chen, Hongyu
    Xu, Xiaoyuan
    Kang, Qian
    Han, Yifan
    Pan, Jiali
    Zeng, Zhan
    Yu, Yanyan
    HEPATOLOGY, 2023, 78 : S742 - S743